Teleflex (TFX) Income from Continuing Operations (2009 - 2026)
Teleflex's (TFX) quarterly Income from Continuing Operations came in at $41.8 million in Q2 2026, down 38.74% on a YoY basis from $68.2 million in Q2 2025, and up 963.21% quarter-over-quarter from -$4.8 million in Q1 2026.
Analysis
Teleflex (TFX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Teleflex (TFX) has reported Income from Continuing Operations for 18 consecutive years, with $41.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Continuing Operations fell 38.74% year-over-year to $41.8 million; the trailing twelve-month figure through Jun 2026 stood at -$122.2 million (down 249.44% YoY), and the FY2025 full-year result was $58.5 million, up 2.34% from the prior year.
- Income from Continuing Operations advanced to $41.8 million in Q2 2026 per TFX's latest filing, from -$4.8 million in the prior quarter.
- Across five years, Income from Continuing Operations topped out at $249.7 million in Q4 2025 and bottomed at -$408.9 million in Q3 2025.
- Historically, Income from Continuing Operations has averaged $31.2 million across 5 years, with a median of $77.3 million in 2022.
- The widest YoY moves for Income from Continuing Operations: up 266.89% in 2025, down 468.63% in 2025.
- Over 5 years, Income from Continuing Operations stood at $78.1 million in 2022, then sank by 334.11% to -$182.9 million in 2023, then climbed by 18.18% to -$149.6 million in 2024, then surged by 266.89% to $249.7 million in 2025, then slumped by 83.28% to $41.8 million in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered $41.8 million, -$4.8 million, and $249.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Teleflex | 5.76 Bn | 5.46 Bn | 331.71 Mn | 41.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.76 Mn |
| Mar 31, 2026 | -4.84 Mn |
| Dec 31, 2025 | 249.72 Mn |
| Sep 28, 2025 | -408.88 Mn |
| Jun 29, 2025 | 68.18 Mn |
| Mar 30, 2025 | 52.33 Mn |
| Dec 31, 2024 | -149.63 Mn |
| Sep 29, 2024 | 110.92 Mn |
| Jun 30, 2024 | 80.17 Mn |
| Mar 31, 2024 | 15.74 Mn |
| Dec 31, 2023 | -182.87 Mn |
| Oct 1, 2023 | 137.67 Mn |
| Jul 2, 2023 | 111.42 Mn |
| Apr 2, 2023 | 77.30 Mn |
| Dec 31, 2022 | 78.11 Mn |
| Sep 25, 2022 | 101.88 Mn |
| Jun 26, 2022 | 105.56 Mn |
| Mar 27, 2022 | 77.37 Mn |
| Dec 31, 2021 | 127.46 Mn |
| Sep 26, 2021 | 199.51 Mn |